Team
Patrick Page, PhD, MBA
Managing Partner
Education:
PhD, Biochemistry, Medicinal Chemistry, Uni. of Toulouse; MBA, Management in Healthcare, INSEEC Paris; Certificate Business creation, EPFL Lausanne
Key Expertise:
Scientific and technical: translational science, drug discovery and development planning and strategy, candidate drug identification and selection, medicinal chemistry, ADME/PK (H2L, LO, clinical development), preclinical and non-clinical development, IND-enabling preclinical package, project/program management; scientific advisor board member for several young biotech companies
Business: Innovation strategy, strategic alliance agreements, licensing in/out and transaction agreements, M&A, product positioning, product portfolio strategy, program/product due diligence for VCs and biotech companies, business plan writing and review, coaching of project owner during start-up maturation/acceleration phase, fund raising (local/national funding, Venture capitalists, business angels), biotech entrepreneur
Previous Experience:
Crown Bioscience (US): Corporate Development Director Europe; Conicmeds SAS (FR): Chief Development Officer and part-time CEO; Epiremed SAS (FR): CEO/CSO; Genkyotex SA (CH): CEO/CSO/CDO; Serono Pharma (CH) : Senior Project Director Preclinical Development; Astrazeneca (SE) : Project Director drug discovery programs
Partners
Decode Pharma Partners oversees and coordinates your drug discovery and development program involving a unique network of seasoned professionals from the pharmaceutical industry and academia with demonstrated long-term evidence of success and achievements in the following areas:
- Pharmacology
- Pharmacokinetics
- Toxicology
- Clinical development
- Compound Manufacturing and Control (CMC)
- Regulatory Affairs
